特異性COX-2抑制劑在肝癌肝切除術(shù)患者ERAS中的臨床應(yīng)用
[Abstract]:Objective: To study the analgesic effect of specific COX-2 inhibitor in the post-hepatectomy of patients with liver cancer. Methods:90 patients with hepatic resection of liver cancer were selected from the first hospital in Jilin University from April 2015 to December 2015. The experimental group and the control group were randomly divided into the experimental group and the control group according to the criteria of the inclusion and the exclusion criteria. Intramuscular injection of 2 ml of saline was administered intramuscularly every 12 hours after 72 hours after the control group, and the test group was given an intramuscular injection specific COX-2 inhibitor every 12 hours after 72 hours of operation. The operative data of the two groups of patients were recorded by the statistical method. The first time after the operation, the first time after operation, the post-operative hospitalization, the postoperative hospital stay, the number of opioid analgesic after 72 hours after operation, the postoperative 3-day pain score, the postoperative complications, the adverse reaction, etc. Results: Compared with the control group, the first time after the operation of the experimental group, the first time after the operation, the time of the hospital stay was significantly shortened, the hospital cost was reduced, the number of opioid drugs was decreased in 72 hours after operation, and the pain score of 3 days after operation was reduced. The number of pleural effusion, nausea and vomiting and the number of respiratory depression were reduced after operation, and the difference was statistically significant (P <0.05). Conclusion: The use of specific COX-2 inhibitor is safe and effective in the early stage of the patients with liver cancer, and can obviously relieve the pain degree after the liver resection of the liver cancer of the patient, promote the recovery after the operation of the patient, reduce the hospitalization time, the hospitalization expense and the dosage of the postoperative opioid. It is a good choice for patients with liver cancer after hepatectomy.
【學(xué)位授予單位】:吉林大學(xué)
【學(xué)位級(jí)別】:碩士
【學(xué)位授予年份】:2016
【分類號(hào)】:R735.7
【參考文獻(xiàn)】
相關(guān)期刊論文 前10條
1 冷希圣;韋軍民;劉連新;江志偉;吳育連;何裕隆;陳孝平;陳亞進(jìn);苗毅;莢衛(wèi)東;洪德飛;唐健雄;梁存河;彭志海;彭林;竇科峰;樓文暉;;普通外科圍手術(shù)期疼痛處理專家共識(shí)[J];中華普通外科雜志;2015年02期
2 ;肝切除術(shù)圍手術(shù)期過度炎癥反應(yīng)調(diào)控的多學(xué)科專家共識(shí)(2014版)[J];中華消化外科雜志;2014年10期
3 石紅英;;術(shù)后早期運(yùn)動(dòng)護(hù)理對(duì)腹部手術(shù)患者胃腸功能及術(shù)后疼痛的影響[J];國際護(hù)理學(xué)雜志;2014年03期
4 蒲江北;朱淑萍;丁久韋;劉碧華;曲學(xué)華;;舒芬太尼靜脈自控鎮(zhèn)痛對(duì)于腹部手術(shù)后患者的鎮(zhèn)痛效果及胃腸功能的影響[J];現(xiàn)代生物醫(yī)學(xué)進(jìn)展;2013年22期
5 鄒朝瓊;楊紅;;腹部手術(shù)后應(yīng)用自控鎮(zhèn)痛泵的護(hù)理體會(huì)[J];黔南民族醫(yī)專學(xué)報(bào);2011年02期
6 王慶;李真;王志鵬;崔燦;;帕瑞昔布鈉在腹腔鏡結(jié)腸癌根治術(shù)中的超前鎮(zhèn)痛作用[J];南方醫(yī)科大學(xué)學(xué)報(bào);2010年11期
7 莫怡芬;韋樹梅;唐瑛;;剖宮產(chǎn)術(shù)后自控鎮(zhèn)痛泵對(duì)產(chǎn)婦早期泌乳及腸蠕動(dòng)的影響[J];右江醫(yī)學(xué);2010年02期
8 戎利民;蔡道章;董健文;劉斌;史德海;;羅哌卡因局部浸潤用于顯微內(nèi)鏡腰椎間盤切除術(shù)后鎮(zhèn)痛[J];中國醫(yī)院藥學(xué)雜志;2008年18期
9 瞿慧;王春光;封小美;胡益明;段滿林;徐建國;;術(shù)前服用加巴噴丁對(duì)胃癌患者術(shù)后曲馬多鎮(zhèn)痛的影響[J];臨床麻醉學(xué)雜志;2007年09期
10 鄭麗宏;梁潔;王國年;吳華星;;經(jīng)皮穴位電刺激對(duì)胃癌根治術(shù)患者圍術(shù)期細(xì)胞因子及術(shù)后鎮(zhèn)痛效果的影響[J];中華麻醉學(xué)雜志;2007年05期
,本文編號(hào):2511669
本文鏈接:http://sikaile.net/yixuelunwen/zlx/2511669.html